10-Q: Mannatech Reports Q1 2024 Results: Net Income Rises Despite Revenue Dip
Quarterly Report
Mannatech's first quarter 2024 results show an increase in net income despite a decrease in net sales compared to the same period last year.
Summary
- Mannatech's net sales for the first quarter of 2024 were $29.4 million, a decrease of 13.8% compared to $34.1 million in the first quarter of 2023.
- The company experienced a $4.7 million decrease in net sales, with a $3.9 million decrease on a constant dollar basis and a $0.8 million decrease due to unfavorable foreign exchange.
- Income from operations increased to $0.8 million, compared to $0.7 million in the same period last year, despite the revenue decline.
- Net income for the quarter was $1.2 million, or $0.63 per diluted share, compared to $0.6 million, or $0.32 per diluted share, in the first quarter of 2023.
- The company's gross profit margin improved to 78.6% from 78.3% due to reduced freight and shipping costs and other supply chain initiatives.
- Selling and administrative expenses decreased by $1.9 million, or 15.5%, due to cost reductions and management-initiated cost controls.
Sentiment
Score: 5
Explanation: The document presents mixed results. While net income improved and costs were reduced, the significant decrease in net sales and associate recruitment is concerning. The need for a capital raise also indicates potential financial strain. Overall, the sentiment is neutral to slightly negative.
Positives
- Net income increased significantly year-over-year.
- Gross profit margin improved due to supply chain efficiencies.
- The company successfully reduced selling and administrative expenses.
- Cash and cash equivalents increased slightly.
Negatives
- Net sales decreased by 13.8% compared to the same quarter last year.
- The Asia/Pacific region experienced a significant decline in sales.
- Recruitment of new independent associates and preferred customers decreased by 13.6%.
Risks
- The company's future liquidity depends on maintaining or improving revenue compared to operational expenses.
- Failure to successfully implement the 2024 business reorganization plan could negatively impact sales and liquidity.
- Disruptions in the supply chain or decreases in consumer demand could adversely affect the company's financial performance.
- The company may need to raise additional funds if existing capital resources are insufficient.
- The company is exposed to currency exchange rate fluctuations which could impact financial results.
Future Outlook
The company believes its existing liquidity and cash flows from operations are adequate to fund normal expected future business operations for the next twelve months, but this is dependent on maintaining or improving revenue as compared to operational expenses. The company has a 2024 business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction.
Management Comments
- Management has established a 2024 business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction.
- Management is focused on improving margin through a price increase, continued focus on supply chain costs, and certain compensation plan adjustments.
- Management is reorganizing certain functional operations and reducing fixed selling and administrative overhead.
Industry Context
The company operates in the competitive nutritional supplements industry, which is subject to regulatory changes and market fluctuations. The company's performance is affected by its ability to attract and retain independent associates and preferred customers, as well as its ability to manage costs and adapt to market conditions.
Comparison to Industry Standards
- Mannatech's Q1 2024 results show a mixed performance compared to industry standards. While the company improved its net income and gross profit margin, the decrease in net sales is a concern.
- Companies like Herbalife and Nu Skin, which also operate in the direct selling space, have faced similar challenges in recent years, including declining sales and regulatory scrutiny.
- Mannatech's focus on cost reduction and supply chain improvements aligns with industry best practices for managing profitability in a competitive market.
- The company's reliance on network marketing distribution channels makes it vulnerable to changes in associate recruitment and retention, which is a common challenge in the industry.
- Compared to other companies in the nutritional supplement industry, Mannatech's performance is below average in terms of revenue growth, but above average in terms of cost control.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Alfredo (Al) Bala | Landen Fredrick | April 1, 2024 | Retirement of previous CEO |
| Interim Chief Financial Officer | NA | Landen Fredrick | April 1, 2024 | Interim appointment |
Legal Proceedings
- As of March 31, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary.
Related Party Transactions
- The company entered into three separate unsecured Loan Agreement and Promissory Notes with three related parties, who are all current members of the Companys Board of Directors and stockholders of the Company, in an aggregate principal amount of $3.6 million.
Stakeholder Impact
- Shareholders may be concerned about the decrease in net sales, but encouraged by the increase in net income and cost reductions.
- Employees may be affected by the reorganization and cost reduction efforts.
- Associates and preferred customers may be impacted by changes in compensation plans and incentives.
- Suppliers may be affected by changes in purchasing commitments.
Next Steps
- The company will focus on implementing its 2024 business reorganization plan.
- The company will continue to monitor its compliance with Nasdaq continued listing rules.
- The company will focus on improving revenue and managing costs.
Key Dates
| Date | Description |
|---|---|
| November 4, 1993 | Mannatech, Incorporated was incorporated in the state of Texas. |
| April 17, 2017 | The Mannatech, Incorporated 2017 Stock Incentive Plan was adopted by the Board of Directors. |
| June 8, 2017 | The Mannatech, Incorporated 2017 Stock Incentive Plan was approved by shareholders. |
| February 2019 | The Mannatech, Incorporated 2017 Stock Incentive Plan was amended by the Board of Directors. |
| June 11, 2019 | The amendment to the Mannatech, Incorporated 2017 Stock Incentive Plan was approved by shareholders. |
| March 10, 2023 | The company entered into a five-year agreement to sublease office space in Flower Mound, Texas. |
| March 13, 2024 | The company announced the retirement of Alfredo (Al) Bala as CEO effective April 1, 2024. |
| March 31, 2024 | End of the first quarter of 2024. |
| April 1, 2024 | Alfredo (Al) Bala's retirement as CEO became effective and he was engaged as an advisor. |
| April 15, 2024 | The company received a fairness opinion on the terms of the Promissory Notes. |
| April 18, 2024 | A supply agreement was amended. |
| April 23, 2024 | The company entered into three unsecured Loan Agreement and Promissory Notes with related parties. |
| April 30, 2024 | Number of shares outstanding of the registrants sole class of common stock was 1,884,814. |
| September 30, 2026 | The Promissory Notes are due in full. |
Keywords
Mannatech, financial results, net sales, net income, gross profit, operating expenses, direct selling, nutritional supplements, network marketing, Asia Pacific, EMEA, Americas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.